文献速递妇科

苹果女性健康研究中通过月经追踪确定的异常子宫出血模式

Abnormal uterine bleeding patterns determined through menstrual tracking among participants in the Apple Women's Health Study.
PubMed 文献 · Am J Obstet Gynecol · 2022-10-29

研究纳入2019年11月至2021年7月苹果女性健康研究中提供月经追踪数据且未孕、未哺乳、未用激素、未绝经的18,875名参与者,确认追踪准确性后异常子宫出血患病率为16.4%,黑人、肥胖及报告多囊卵巢综合征、甲状腺疾病、子宫内膜异位症、宫颈发育不良者患病率更高。

要点

  • 确认月经追踪后异常子宫出血患病率为16.4%(95%CI 15.9-17.0)。
  • 黑人参与者月经过稀患病率较白人非西班牙裔高33%(PR 1.33,95%CI 1.09-1.61)。
  • 3级肥胖者异常子宫出血患病率较健康体重者高18%(PR 1.18,95%CI 1.02-1.38)。

核心结论

  • 在该队列中,确认月经追踪的参与者异常子宫出血患病率为16.4%。
  • 黑人参与者及肥胖参与者异常子宫出血患病率升高。
  • 报告多囊卵巢综合征、甲状腺疾病、子宫内膜异位症及宫颈发育不良的参与者异常子宫出血患病率更高。

研究设计与样本

  • 研究纳入2019年11月至2021年7月苹果女性健康研究中提供月经追踪数据且未报告妊娠、哺乳、使用激素或绝经的参与者。
  • 评估四种异常子宫出血模式:月经不规则、月经过稀、月经过长及经间不规则出血(点滴出血)。
  • 通过调查问卷进行每月追踪确认,以排除不准确或不完整的数字记录。
  • 共18,875名参与者符合纳入标准,平均年龄33岁(标准差8.2),平均体重指数29.3(标准差8.0),68.9%(95%CI 68.2-69.5)自认为白人非西班牙裔。
  • 采用 logistic 回归评估异常子宫出血与多种自报疾病的关系。

主要发现

  • 确认准确追踪后,16.4%的参与者存在异常子宫出血(n=3103;95%CI 15.9-17.0)。
  • 月经不规则占2.9%(95%CI 2.7-3.1),月经过稀占8.4%(95%CI 8.0-8.8),月经过长占2.3%(95%CI 2.1-2.5),点滴出血占6.1%(95%CI 5.7-6.4)。
  • 控制年龄和体重指数后,黑人参与者月经过稀患病率较白人非西班牙裔参与者高33%(患病率比1.33;95%CI 1.09-1.61)。
  • 控制年龄和种族/民族后,1级、2级和3级肥胖者月经过稀患病率升高(1级:BMI 30-34.9,患病率比1.31,95%CI 1.13-1.52;2级:BMI 35-39.9,患病率比1.25,95%CI 1.05-1.49;3级:BMI>40,患病率比1.51,95%CI 1.21-1.88)。
  • 3级肥胖者异常子宫出血患病率较健康体重者高18%(患病率比1.18;95%CI 1.02-1.38);多囊卵巢综合征者较无此病者高19%(患病率比1.19;95%CI 1.08-1.31);甲状腺功能亢进者(患病率比1.34;95%CI 1.13-1.59)、甲状腺功能减退者(患病率比1.17;95%CI 1.05-1.31)、子宫内膜异位症者(患病率比1.28;95%CI 1.12-1.45)、宫颈发育不良者(患病率比1.20;95%CI 1.03-1.39)及子宫肌瘤者(患病率比1.14;95%CI 1.00-1.30)异常子宫出血患病率更高。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Use of menstrual tracking data to understand abnormal bleeding patterns has been limited because of lack of incorporation of key demographic and health characteristics and confirmation of menstrual tracking accuracy. OBJECTIVE: This study aimed to identify abnormal uterine bleeding patterns and their prevalence and confirm existing and expected associations between abnormal uterine bleeding patterns, demographics, and medical conditions. STUDY DESIGN: Apple Women's Health Study participants from November 2019 through July 2021 who contributed menstrual tracking data and did not report pregnancy, lactation, use of hormones, or menopause were included in the analysis. Four abnormal uterine bleeding patterns were evaluated: irregular menses, infrequent menses, prolonged menses, and irregular intermenstrual bleeding (spotting). Monthly tracking confirmation using survey responses was used to exclude inaccurate or incomplete digital records. We investigated the prevalence of abnormal uterine bleeding stratified by demographic characteristics and used logistic regression to evaluate the relationship of abnormal uterine bleeding to a number of self-reported medical conditions. RESULTS: There were 18,875 participants who met inclusion criteria, with a mean age of 33 (standard deviation, 8.2) years, mean body mass index of 29.3 (standard deviation, 8.0), and with 68.9% (95% confidence interval, 68.2-69.5) identifying as White, non-Hispanic. Abnormal uterine bleeding was found in 16.4% of participants (n=3103; 95% confidence interval, 15.9-17.0) after accurate tracking was confirmed; 2.9% had irregular menses (95% confidence interval, 2.7-3.1), 8.4% had infrequent menses (95% confidence interval, 8.0-8.8), 2.3% had prolonged menses (95% confidence interval, 2.1-2.5), and 6.1% had spotting (95% confidence interval, 5.7-6.4). Black participants had 33% higher prevalence (prevalence ratio, 1.33; 95% confidence interval, 1.09-1.61) of infrequent menses compared with White, non-Hispanic participants after controlling for age and body mass index. The prevalence of infrequent menses was increased in class 1, 2, and 3 obesity (class 1: body mass index, 30-34.9; prevalence ratio, 1.31; 95% confidence interval, 1.13-1.52; class 2: body mass index, 35-39.9; prevalence ratio, 1.25; 95% confidence interval, 1.05-1.49; class 3: body mass index, >40; prevalence ratio, 1.51; 95% confidence interval, 1.21-1.88) after controlling for age and race/ethnicity. Those with class 3 obesity had 18% higher prevalence of abnormal uterine bleeding compared with healthy-weight participants (prevalence ratio, 1.18; 95% confidence interval, 1.02-1.38). Participants with polycystic ovary syndrome had 19% higher prevalence of abnormal uterine bleeding compared with participants without this condition (prevalence ratio, 1.19; 95% confidence interval, 1.08-1.31). Participants with hyperthyroidism (prevalence ratio, 1.34; 95% confidence interval, 1.13-1.59) and hypothyroidism (prevalence ratio, 1.17; 95% confidence interval, 1.05-1.31) had a higher prevalence of abnormal uterine bleeding, as did those reporting endometriosis (prevalence ratio, 1.28; 95% confidence interval, 1.12-1.45), cervical dysplasia (prevalence ratio, 1.20; 95% confidence interval, 1.03-1.39), and fibroids (prevalence ratio, 1.14; 95% confidence interval, 1.00-1.30). CONCLUSION: In this cohort, abnormal uterine bleeding was present in 16.4% of those with confirmed menstrual tracking. Black or obese participants had increased prevalence of abnormal uterine bleeding. Participants reporting conditions such as polycystic ovary syndrome, thyroid disease, endometriosis, and cervical dysplasia had a higher prevalence of abnormal uterine bleeding.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Zhang CY, Li H, Zhang S, et al. Abnormal uterine bleeding patterns determined through menstrual tracking among participants in the Apple Women's Health Study. Am J Obstet Gynecol. 2022. PMID: 36414993. doi:10.1016/j.ajog.2022.10.029

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。